Skip to Main Content

3/2 CDC Webinar: What Clinicians Need to Know about the Janssen COVID-19 Vaccine

Date: 03/01/21

On February 27, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen/Johnson & Johnson COVID-19 vaccine. Shortly after, the Advisory Committee on Immunization Practices (ACIP) recommended this first single-shot vaccine for individuals 18 years of age and older. This vaccine uses a non-replicating viral vector platform, and has been found to be safe and effective.

The Centers for Disease Control and Prevention (CDC) will host a Clinician Outreach and Communication Activity (COCA) call on Tuesday, March 2, 2021 to educate providers on the latest vaccine.

Webinar Details

Topic: What Clinicians Need to Know About the Janssen COVID-19 Vaccine
Date: Tuesday, March 2, 2021
Time: 1:00 – 2:00 p.m. CDT
Description: This COCA call will give clinicians an overview of the Janssen COVID-19 vaccine. Clinicians will learn about vaccine characteristics and administration, vaccinating special populations and contraindications. They will also get answers to a number of clinical questions CDC has received about this new vaccine.
Event link: https://emergency.cdc.gov/coca/calls/2021/callinfo_030221.asp

Additional Janssen Vaccine Resources

  • Janssen COVID-19 EUA Fact Sheet (PDF)
  • Janssen COVID-19 EUA Letter of Authorization (PDF)

General COVID-19 Vaccine Resource